Last updated on September 2020

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis Gastric Ulcer or Duodenal Ulcer

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Gastric Ulcers | Duodenal Ulcers | Duodenal Ulcer | Gastric ulcer | REFLUX ESOPHAGITIS
  • Age: Between 1 - 14 Years
  • Gender: Male or Female

Inclusion Criteria:

For healed reflux esophagitis study

  • Endoscopically verified reflux esophagitis, Grade A or higher according to the Los Angels classification as judged by central evaluation committee.

For prevention of gastric ulcer or duodenal ulcer recurrence study

  • Patients with documented medical history of gastric ulser or duodenal ulser diagnosis based on upper gastrointestinal symptoms, fecal occult blood, esophagogastroduodenoscopy findings, etc.

Exclusion Criteria:

  • Patients less than 10 kg in weight.
  • Use of any other investigational compounds or participations in another clinical trial within 4 weeks prior to the enrolment.
  • Significant clinical illness within 4 weeks prior to the informed consent
  • Previous total gastrectomy.
  • Presence of hepatic diseases or other conditions that could interfere with evaluation of the study as judged by investigators. etc

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.